Transmission dynamics of hepatitis C virus among intra venous drug users in the border state of Manipur, India

Infection, Genetics and Evolution

Volumn 24, Issue , 2014, Pages 57-67

  Saha, Kallol ^a   Firdaus, Rushna ^a   Biswas, Aritra ^a   Mukherjee, Anirban ^a   Sarkar, Kamalesh ^b   Chakrabarti, Sekhar ^a   Sadhukhan, Provash Chandra ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Drug trafficking; Intra venous drug users; Phylogeographic analysis; Recombinant HCV; Transmission risk reduction

Indexed keywords

VIRUS RNA; CORE PROTEIN; HEPATITIS C ANTIBODY; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INCIDENCE; INDIA; INTRAVENOUS DRUG ABUSE; MALE; MOLECULAR EPIDEMIOLOGY; MULTICENTER STUDY; MYANMAR; NUCLEOTIDE SEQUENCE; PHYLOGEOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIET NAM; VIRUS GENOME; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION; BLOOD; CLASSIFICATION; CLINICAL TRIAL; DRUG TRAFFIC; DRUG USE; EPIDEMIOLOGY; GENETICS; HEPACIVIRUS; HEPATITIS C; PATHOGENICITY; SUBSTANCE ABUSE; TRANSMISSION;

BASE SEQUENCE; COHORT STUDIES; DRUG TRAFFICKING; DRUG USERS; FEMALE; GENETIC VARIATION; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INDIA; MALE; MOLECULAR EPIDEMIOLOGY; PHYLOGEOGRAPHY; PROSPECTIVE STUDIES; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL CORE PROTEINS; VIRAL LOAD; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84897068398     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.03.008     Document Type: Article

References (47)

1. Abrignani S., Houghton M., Hsu H.H. Perspectives for a vaccine against hepatitis C virus. J. Hepatol. 1999, 31(1):259-263.
2. Aceijas C., Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int. J. Drug Policy 2007, 18(5):352-358.
3. Adinolfi L.E., Gambardella M., Andreana A., Tripodi M.F., Utili R., Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001, 33(6):1358-1364.
4. Bukh J., Purcell R.H., Miller R.H. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc. Natl. Acad. Sci. USA 1992, 89(1):187-191.
5. Cantaloube J.F., Laperche S., Gallian P., Bouchardeau F., de Lamballerie X., de Micco P. Analysis of the 5' non-coding region versus the NS5B region in genotyping hepatitis C virus isolates from blood donors in France. J. Clin. Microbiol. 2006, 44(6):2051-2056.
6. Chen Y.D., Liu M.Y., Yu W.L., Li J.Q., Peng M., Dai Q., Wu J., Liu X., Zhou Z.Q. Sequence variability of the 5'UTR in isolates of hepatitis C virus in China. Hepatobiliary Pancreat. Dis. Int. 2002, 1(4):541-552.
7. Cochrane A., Searle B., Hardie A., Robertson R., Delahooke T., Cameron S., Tedder R.S., Dusheiko G.M., De Lamballerie X., Simmonds P. A genetic analysis of hepatitis C virus transmission between injection drug users. J. Infect. Dis. 2002, 186(9):1212-1221.
8. Colina R., Casane D., Vasquez S., García-Aguirre L., Chunga A., Romero H., Khan B., Cristina J. Evidence of intratypic recombination in natural populations of hepatits C virus. J. Gen. Virol. 2004, 85(1):31-37.
9. Cristina J., Colina R. Evidence of structural genomic region recombination in hepatitis C Virus. Virol. J. 2006, 3:53.
10. Diamantis I. High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. J. Hepatol. 1997, 26(4):794-797.
11. Drummond A.J., Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 2007, 7:214.
12. Firdaus R., Saha K., Sadhukhan P.C. Rapid immunoassay alone is insufficient for the detection of hepatitis C virus infection among high-risk population. J. Viral. Hep. 2013, 20(4):290-293.
13. Hagan H., Des Jarlais D.C. HCV and HIV coinfection among Injection drug users. Mt. Sinai J. Med. 2000, 67(5-6):423-428.
14. Hasegawa M., Kishino H., Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J. Mol. Evol. 1985, 22(2):160-174.
15. HIV Sentinel surveillance and HIV estimation in India 2007. A technical brief. National AIDS Control Organization. Ministry of health and Family welfare, Government of India, New Delhi . http://www.nacoonline.org.
16. Kageyama S., Agdamag D.M., Alesna E.T., Leano P.S., Heredia A.M., Abellanosa-Tac-An I.P., Jereza L.D., Tanimoto T., Yamamura J., Ichimura H. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Phillipines. J. Med. Virol. 2006, 78(11):1423-1428.
17. Kalinina O., Norder H., Magnius L.O. Full length open reading frame of a recombinant hepatitis C virus strain from St Petersberg: proposed mechanism for its formation. J. Gen. Virol. 2004, 85(7):1853-1857.
18. Lee Y.M., Lin H.J., Chen Y.J., Lee C.M., Wang S.F., Chang K.Y., Chen T.L., Liu H.F., Chen Y.M. Molecular epidemiology of HCV genotypes among Injection drug users in Taiwan: Full length sequences of two new subtypes 6w strains and a recombinant form 2b6w (Taiwan). J. Med. Virol. 2010, 82(1):57-68.
19. Legrand-Abravanel F., Claudinon J., Nicot F., Dubois M., Chapuy-Regaud S., Sandres-Saune K., Pasquier C., Izopet J. A new natural intergenotypic (2/5) recombinant of hepatitis C virus. J. Virol. 2007, 81(8):4357-4362.
20. Lindenbach B.D., Rice C.M. Unravelling hepatitis C virus replication from genome to function. Nature 2005, 18-436(7053):933-938.
21. Luna G.C. Use and abuse of amphetamine-type stimulants in United States. Pan. Am. J. Public. Health. 2001, 9. (pp. 114-12).
22. Lwin A.A., Shinji T., Khin M., Win N., Obika M., Okada S., Koide N. Hepatitis C virus genotype distribution in Myanmar: predominance of genotype 6 and existence of new genotype 6 subtype. Hepatol. Res. 2007, 37(5):337-345.
23. Magiorkinis G., Magiorkinis E., Paraskevis D., Ho S.Y., Shapiro B., Pybus O.G., Allain J.P., Hatzakis A. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med. 2009, 6(12):e1000198.
24. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., Wodak A., Panda S., Tyndall M., Toufik A., Mattick R.P. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372(9651):1733-1745.
25. Medhi G.K., Mahanta J., Adhikary R., Akoijam B.S., Liegise B., Sarathy K., Thomas C.J., Sarmah B. Spatial distribution and characteristics of injection drug users (IDU) in five north eastern states of India. BMC Public Health 2011, 11:64.
26. Mizokami M., Tanaka Y., Miyakawa Y. Spread times of hepatitis C virus estimated by the molecular clock differ among Japan, the United States and Egypt in reflection of their distinct socioeconomic backgrounds. Intervirology 2006, 49(1-2):28-36.
27. Moreno M., Casane D., Lopez L., Cristina J. Evidence of recombination in quasispecies population of a hepatitis C virus patient undergoing antiviral therapy. Virol. J. 2006, 3:87.
28. Mukhopadhya A. Hepatitis C in India. J. Biosci. 2008, 33:465-473.
29. Nakano T., Lu L., Liu P., Pybus O.G. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J. Infect. Dis. 2004, 190(6):1098-1108.
30. National AIDS control organization, Ministry of Health and Family welfare, Government of India. 2006. Technical report India HIV estimates, National AIDS control Society (http://www.nacoonline.org).
31. Negro F. HCV causes systemic disorders that can be cured. Nat. Rev. Gastroenterol. Hepatol. 2013, 11:77-78.
32. Noppornpanth S., Lien T.X., Poovorawan Y., Smits S.L., Osterhaus A.D., Haagmans B.L. Identification of naturally occurring recombinant genotypes 2/6 hepatitis C virus. J. Virol. 2006, 80(15):7569-7577.
33. Paraskevis D., Pybus O., Magiorkinis G., Hatzakis A., Wensing A.M., van de Vijver D.A., Albert J., Angarano G., Asjo B., Balotta C., Boeri E., Camacho R., Chaix M.L., Coughlan S., Costagliola D., De Luca A., de Mendoza C., Derdelinckx I., Grossman Z., Hamouda O., Hoepelman I., Horban A., Korn K., Kucherer C., Leitner T., Loveday C., Macrae E., Maljkovic-Berry I., Meyer L., Nielsen C., Op de Coul E.L., Ormaasen V., Perrin L., Puchhammer-Stockl E., Ruiz L., Salminen M.O., Schmit J.C., Schuurman R., Soriano V., Stanczak J., Stanojevic M., Struck D., Van Laethem K., Violin M., Yerly S., Zazzi M., Boucher C.A., Vandamme A.M. Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology 2009, 6:49.
34. Pham S., Bull R., Bennett W., Dore G., Llyod A., White P. Frequent multiple HCV infection s among injecting drug users in a prison setting. Hepatology 2010, 52:1564-1572.
35. Prince A.M., Shata M.T. Immunoprophylaxis of hepatitis C virus infection. Clin. Liv. Dis. 2001, 5(4):1091-1103.
36. Pybus O.G., Charleston M.A., Gupta S., Rambaut A., Holmes E.C., Harvey P.H. The epidemic behavior of the hepatitis C virus. Science 2001, 292(5525):2323-2325.
37. Reed K.E., Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 2000, 242:55-84.
38. Rong X., Lu L., Wang J., Xiong H., Huang J., Chen J., Huang K., Xu R., Wang M., Zhang X., Guo T., Liu Y., Gao G., Fu Y., Nelson K.E. Correlation of viral loads with HCV genotypes. Higher levels of viruses were revealed among blood donors infected with 6a strains. PLoS One 2012, 7(12):e52467.
39. Roudot-Thoraval F. Modifications of epidemiological characteristics of HCV infection. Gastroenterol. Clin. Biol. 2002, 26(2):B138-B143.
40. Saha M.K., Chakrabarti S., Panda S., Naik T.N., Manna B., Chatterjee A., Detels R., Bhattacharya S.K. Prevalence of HCV and HBV infection amongst HIV seropositive intravenous drug users and their non injecting wives in Manipur. Indian J. Med. Res. 2000, 111:37-39.
41. Saha K., Firdaus R., Santra P., Pal J., Roy A., Bhattacharya M.K., Chakrabarti S., Sadhukhan P.C. Recent pattern of co-infection amongst HIV seropositive individuals in Tertiary Care Hospital, Kolkata. Virol. J. 2011, 8:116.
42. Sharma M., Oppenheimer E., Saidel T., Loo V., Garg R. A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region. AIDS 2009, 23(3):S62-S71.
43. Slatkin M., Maddison W.P. A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 1989, 123(3):603-613.
44. Smith D.B., Bukh J., Kuiken C., Muerhoff A.S., Rice C.M., Stapleton J.T., Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatology 2014, 59(1):318-327.
45. Wallace R.G., Hodac H., Lathrop R.H., Fitch W.M. A statistical phylogeography of influenza A H5N1. Proc. Natl. Acad. Sci. USA 2007, 104(11):4473-4478.
46. Zhang C., Wu N., Liu J., Ge Q., Huang Y., Ren Q., Feng Q., He G. HCV Subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China. PLoS One 2011, 6(2):e16817.
47. Zwickl, D.J., 2006. Genetic Algorithm Approaches for the Phylogenetic Analysis of Large Biological Sequence Datasets Under the Maximum Likelihood Criterion (Ph.D. dissertation). The University of Texas at Austin.